Articles tagged with Atopic Dermatitis
The ADVN aims to understand immune responses in AD patients after natural exposure to skin viruses and investigate their reactions to the smallpox vaccine. The network will inform safer vaccine design, improving protection against the smallpox virus without life-threatening complications.
Researchers at OHSU are conducting a study to investigate whether early treatment with the eczema drug Elidel can prevent asthma in children with a family history of allergic disease. The study aims to enroll 200 infants with eczema and assess whether early intervention reduces the incidence of asthma.
A six-year prospective study will investigate whether early treatment with pimecrolimus can reduce or prevent the need for corticosteroids and subsequent development of asthma. Researchers hope that effective topical treatment of eczema in its early stages may help prevent later allergic diseases, such as asthma.
Early detection and treatment of allergies can prevent serious complications and modify the progression of pediatric allergies. A specific IgE blood test can accurately diagnose atopy and guide treatment, including avoidance therapy and medication.
Researchers found that early exposure to probiotics Lactobacillus GG reduced the risk of atopic eczema by 40% in children at four years old. The study suggests a potential preventive effect against eczema in infancy and childhood.
A study found that 10 days of doxycycline antibiotic therapy is as effective as a 20-day course for early Lyme disease. Additionally, researchers discovered that many people cannot accurately recall if they or family members had skin diseases contraindicating smallpox vaccination, potentially increasing the risk of widespread vaccination.
Researchers found that eczema patients have impaired immune response, preventing adequate antimicrobial peptide production in their skin. This deficiency may lead to increased susceptibility to skin infections, such as staphylococcus aureus and herpes simplex.
Researchers have found that tacrolimus can effectively treat moderate-to-severe atopic dermatitis in children, with a success rate of 67-70% and minimal systemic side effects. This treatment approach offers an alternative to corticosteroid ointments, which can cause skin thinning and other complications.